Yüklüyor......

Recent Advances in the Development of Immunotherapies for Tauopathies

The use of immunotherapy for Alzheimer’s Disease (AD) has traditionally focused on the amyloid-β (Aβ) peptide and has shown great potential in both animal and human studies. However an emerging body of work has begun to concentrate on tau and to develop immunization protocols designed to decrease ta...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Ubhi, Kiren, Masliah, Eliezer
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2010
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3125641/
https://ncbi.nlm.nih.gov/pubmed/20970422
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.expneurol.2010.10.007
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!